Mitochon Pharmaceuticals, Inc. logo

Mitochon Pharmaceuticals, Inc.

Harnessing the Power of Mitochondria to Create Resilient, Protective Cells in Neurodegeneration and Aging

4 employees · est. 2014 · United States

VS
Tetralogic Pharmaceuticals logo

Tetralogic Pharmaceuticals

10 employees · est. 2001

Tetralogic Pharmaceuticals is the older company (2014 vs 2001).

Side-by-Side Comparison

Mitochon Pharmaceuticals, Inc. Tetralogic Pharmaceuticals
Founded
2014 2001 older
Headquarters
United States Not tracked yet
Employees
4 10
Industry
Biopharma, Biotechnology, Pharmaceutical Biotechnology, Health Care, Pharmaceutical
Funding Stage
Series Unknown Convertible Note
Total Funding
$2.33M $164.00M
Funding Rounds
3 9
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Biotech, Mitochondria, Neurodegenerative Diseases, Drug Development, Neuroprotection, Mitochondrial Enhancers, Clinical-stage, Brain Penetrating Therapy, Disease Modifying Therapies, Executive Team, Pharmaceuticals, Aging, Free Radical Production, ATP Production, Mechanism Of Action Biopharmaceutical Company, Clinical-stage, Cancer Treatment, Infectious Diseases, Small Molecule Drugs, Programmed Cell Death Pathways, Smac Mimetics, Necrostatin Drugs, Apoptosis Pathway, Necrosis, Drug Discovery, Drug Development, Clinical Trials, Oncology, Pharmaceutical Research
Website
mitochonpharma.com tetralogicpharma.com
Mitochon Pharmaceuticals, Inc. logo

About Mitochon Pharmaceuticals, Inc.

Mitochon Pharmaceuticals, Inc. is a biotech startup founded in 2014, headquartered in the United States. The company's slogan "Harnessing the Power of Mitochondria to Create Resilient, Protective Cells in Neurodegeneration and Aging" reflects its focus on developing drugs that target mitochondria to...

Tetralogic Pharmaceuticals logo

About Tetralogic Pharmaceuticals

Tetralogic Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, acquiring, and developing novel product candidates to treat cancer and infectious diseases. Founded in 2001, the company currently has two clinical-stage product candidates in development: birinapant and...

We will tell you when either one moves

BounceWatch watches Mitochon Pharmaceuticals, Inc. and Tetralogic Pharmaceuticals for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Mitochon Pharmaceutica... and Tetralogic Pharmaceuti... — by email.

Frequently Asked Questions

Mitochon Pharmaceuticals, Inc. — Harnessing the Power of Mitochondria to Create Resilient, Protective Cells in Neurodegeneration and Aging. Tetralogic Pharmaceuticals. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Mitochon Pharmaceuticals, Inc. has raised $2.33M while Tetralogic Pharmaceuticals has raised $164.00M.
Mitochon Pharmaceuticals, Inc. and Tetralogic Pharmaceuticals operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Mitochon Pharmaceuticals, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Mitochon Pharmaceuticals, Inc. on 12 Sep 2024, and Tetralogic Pharmaceuticals on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes